Synthesis, characterization and anticancer activities of transition metal complexes with a nicotinohydrazone ligand

Shen,Shanshan; Chen,Hong; Zhu,Taofeng; Ma,Xiuqin; Xu,Jun; Zhu,Wenjiao; Chen,Ruhua; Xie,Jing; Ma,Tieliang; Jia,Lei; Wang,Yuan; Peng,Chunyan

doi:10.3892/ol.2017.5857

Synthesis, characterization and anticancer activities of transition metal complexes with a nicotinohydrazone ligand

Authors:
- Shanshan Shen
- Hong Chen
- Taofeng Zhu
- Xiuqin Ma
- Jun Xu
- Wenjiao Zhu
- Ruhua Chen
- Jing Xie
- Tieliang Ma
- Lei Jia
- Yuan Wang
- Chunyan Peng
View Affiliations

Affiliations: Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing University, Nanjing, Jiangsu 210008, P.R. China, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu 214200, P.R. China, Department of Physics and Chemistry, Henan Polytechnic University, Jiaozuo, Henan 454000, P.R. China
Published online on: March 14, 2017 https://doi.org/10.3892/ol.2017.5857
Pages: 3169-3176

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The reaction of divalent transition metal salts and (E)-N'-(1-(pyridin-2-yl)ethylidene)nicotinohydrazide (penh) led to the formation of [Mn(penh)2] (complex 1), [Co(penh)2] (complex 2), [Cu(penh)2] (complex 3) and [Cd (penh)2] (complex 4) complexes. The four complexes were characterized using elemental analyses, infrared spectra and single‑crystal X‑ray diffraction analyses. Subsequently, the complexes were used for in vitro cell level experiments to determine potential antitumor effects. The results demonstrated that the complexes exhibited a similar structure; however, they were crystallized with distinct space groups. In comparison with the uncomplexed penh ligand, all four complexes were able to markedly decrease the proliferation rate of various types of tumor cell, including the human lung cancer cell line A549, human gastric cancer cell line BGC823 and human esophageal cancer cell line Eca109, in a concentration‑dependent manner. Furthermore, the complexes promoted tumor cell apoptosis, as demonstrated in the apoptosis assay, and this was confirmed using electrophoresis.

View Figures

View References

1	Howard RA, Sherwood E, Erck A, Kimball AP and Bear JL: Hydrophobicity of several rhodium (II) carboxylates correlated with their biologic activity. J Med Chem. 20:943–946. 1977. View Article : Google Scholar : PubMed/NCBI
2	Melnyk P, Leroux V, Sergheraert C and Grellier P: Design, synthesis and in vitro antimalarial activity of an acylhydrazone library. Bioorg Med Chem Lett. 16:31–35. 2006. View Article : Google Scholar : PubMed/NCBI
3	Wardakhan WW, El-Sayed NN and Mohareb RM: Synthesis and anti-tumor evaluation of novel hydrazide and hydrazide-hydrazone derivatives. Acta Pharm. 63:45–57. 2013. View Article : Google Scholar : PubMed/NCBI
4	Aranha PE, dos Santos MP, Romera S and Dockal ER: Synthesis, characterization, and spectroscopic studies of tetradentate Schiff base chromium (III) complexes. Polyhedron. 26:1373–1382. 2007. View Article : Google Scholar
5	Bernhardt PV, Chin P, Sharpe PC, Wang JY and Richardson DR: Novel diaroylhydrazine ligands as iron chelators: Coordination chemistry and biological activity. J Biol Inorg Chem. 10:761–777. 2005. View Article : Google Scholar : PubMed/NCBI
6	Suzen S, Tekiner-Gulbas B, Shirinzadeh H, Uslu D, Gurer-Orhan H, Gumustas M and Ozkan SA: Antioxidant activity of indole-based melatonin analogues in erythrocytes and their voltammetric characterization. J Enzyme Inhib Med Chem. 28:1143–1155. 2013. View Article : Google Scholar : PubMed/NCBI
7	Shaabani B, Khandar AA, Mobaiyen H, Ramazani N, Balula SS and Cunha-Silva L: Novel pseudohalide-bridged Cu(II) complexes with a hydrazone ligand: Evaluation of antimicrobial activity. Polyhedron. 80:166–172. 2014. View Article : Google Scholar
8	Drover MW, Tandon SS, Anwar MU, Shuvaev KV, Dawe LN, Collins JL and Thompson LK: Polynuclear complexes of a series of hydrazone and hydrazone-oxime ligands-M2 (Fe), M4 (Mn, Ni, Cu) and Mn (Cu) examples. Polyhedron. 68:94–102. 2014. View Article : Google Scholar
9	Banerjee S, Sen S, Basak S, Mitra S, Hughes DL and Desplanches C: Two new pseudohalide-bridged Cu (II) complexes with a hydrazone ligand: Syntheses, crystal structures and magnetic studies. Inorganica Chimica Acta. 361:2707–2714. 2008. View Article : Google Scholar
10	Rollas S and Küçükgüzel SG: Biological activities of hydrazone derivatives. Molecules. 12:1910–1939. 2007. View Article : Google Scholar : PubMed/NCBI
11	Narang R, Narasimhan B and Sharma S: A review on biological activities and chemical synthesis of hydrazide derivatives. Curr Med Chem. 19:569–612. 2012. View Article : Google Scholar : PubMed/NCBI
12	Judge V, Narasimhan B and Ahuja M: Isoniazid: The magic molecule. Med Chem Res. 21:3940–3957. 2012. View Article : Google Scholar
13	Vicini P, Zani F, Cozzini P and Doytchinova I: Hydrazones of 1,2-benzisothiazole hydrazides: Synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem. 37:553–564. 2002. View Article : Google Scholar : PubMed/NCBI
14	Kumar P, Narasimhan B, Sharma D, Judge V and Narang R: Hansch analysis of substituted benzoic acid benzylidene/furan-2-yl-methylene hydrazides as antimicrobial agents. Eur J Med Chem. 44:1853–1863. 2009. View Article : Google Scholar : PubMed/NCBI
15	Altintop MD, Özdemir A, Turan-Zitouni G, Ilgın S, Atlı Ö, Demirci F and Kaplancıklı ZA: Synthesis and in vitro evaluation of new nitro-substituted thiazolyl hydrazone derivatives as anticandidal and anticancer agents. Molecules. 19:14809–14820. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhang B, Zhao Y, Zhai X, Wang L, Yang J, Tan Z and Gong P: Design, synthesis and anticancer activities of diaryl urea derivatives bearing N-acylhydrazone moiety. Chem Pharm Bull (Tokyo). 60:1046–1054. 2012. View Article : Google Scholar : PubMed/NCBI
17	Xia Y, Fan CD, Zhao BX, Zhao J, Shin DS and Miao JY: Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Eur J Med Chem. 43:2347–2353. 2008. View Article : Google Scholar : PubMed/NCBI
18	Jia L, Xu J, Zhao X, Shen S, Zhou T, Xu Z, Zhu T, Chen R, Ma T, Xie J, et al: Synthesis, characterization, and antitumor activity of three ternary dinuclear copper (II) complexes with a reduced Schiff base ligand and diimine coligands in vitro and in vivo. J Inorg Biochem. 159:107–119. 2016. View Article : Google Scholar : PubMed/NCBI
19	Sheldrick G: SADABS, Program for Empirical Absorption Correction of Area Detector Data. University of Göttingen; Göttingen, Germany: 1996
20	Sheldrick G: SHELX-97, Program for the Solution and Refinement of Crystal Structures. University of Göttingen; Göttingen, Germany: 1997
21	Singh P, Singh DP and Singh VP: Synthesis, spectral and single crystal X-ray diffraction studies on Mn(II), Ni(II), Cu(II) and Zn(II) complexes with 2-hydroxy-benzoic acid (phenyl-pyridin-2-yl-methylene)-hydrazide. Polyhedron. 81:56–65. 2014. View Article : Google Scholar
22	Krishnamoorthy P, Sathyadevi P, Cowley AH, Butorac RR and Dharmaraj N: Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes. Eur J Med Chem. 46:3376–3387. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lewis FD and Barancyk SV: Lewis acid catalysis of photochemical reactions. 8. Photodimerization and cross-cycloaddition of coumarin. J Am Chem Soc. 111:8653–8661. 1989. View Article : Google Scholar
24	Hao ZY, Liu QW, Xu J, Jia L and Li SB: Synthesis, characterization, antioxidant activities, and DNA-binding studies of (E)-N'-[1-(pyridin-2-yl)ethylidene] isonicotinohydrazide and its Pr (III) and Nd (III) complexes. Chem Pharm Bull (Tokyo). 58:1306–1312. 2010. View Article : Google Scholar : PubMed/NCBI
25	Pflaum J, Schlosser S and Müller M: p53 family and cellular stress responses in cancer. Front Oncol. 4:2852014. View Article : Google Scholar : PubMed/NCBI
26	Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM: p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 11:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
27	Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI